سعر فلومازينيل اينريسا 0.5 مجم / 5 مل 5 امبولات 2022

Flumazenil 0.5 mg/5 ml (0.1 mg/ml) solution for intravenous injection (Inresa Arzneimittel GmbH; Oncopharm Egypt), pack of 5 ampoules.

• Complete or partial reversal of the sedative effects of benzodiazepines after general anaesthesia induced/maintained with benzodiazepines or sedation for diagnostic and therapeutic procedures, and management of benzodiazepine overdose (adults).Population: AdultsDailyMed (U.S. NLM)
• Reversal of conscious sedation induced with benzodiazepines in pediatric patients aged 1 to 17 years.Population: Children 1-17 yearsDailyMed (U.S. NLM)

• Most frequent with flumazenil alone: dizziness, injection-site pain, increased sweating, headache, abnormal or blurred vision; nausea/vomiting (11%), agitation, emotional lability; convulsions are the most common serious event.International label, same formulation · DailyMed (U.S. NLM)

• Known hypersensitivity to flumazenil or benzodiazepines.International label, same formulation · DailyMed (U.S. NLM)
• Patients given a benzodiazepine to control a potentially life-threatening condition (e.g. intracranial pressure or status epilepticus).International label, same formulation · DailyMed (U.S. NLM)
• Patients showing signs of serious cyclic antidepressant overdose.International label, same formulation · DailyMed (U.S. NLM)

• Boxed warning: flumazenil use has been associated with seizures, most frequently in patients on long-term benzodiazepine sedation or with serious cyclic antidepressant overdose; individualise dosing and be prepared to manage seizures.International label, same formulation · DailyMed (U.S. NLM)
• Adjunct to, not a substitute for, airway, ventilation and circulatory support; secure airway and IV access before use; patients may pull out tubes/lines on confused awakening.International label, same formulation · DailyMed (U.S. NLM)

• No adequate and well-controlled studies in pregnant women; use during pregnancy only if the potential benefit justifies the potential risk to the fetus.International label, same formulation · DailyMed (U.S. NLM)
• Not known whether flumazenil is excreted in human milk; caution when giving to a nursing woman.International label, same formulation · DailyMed (U.S. NLM)

• Flumazenil: Competitively blocks the central effects of benzodiazepines at the benzodiazepine receptor; does not reverse opioids, ethanol or barbiturates.